The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
HMG CoA reductase inhibitors (statins) for dialysis patients
|
|---|---|
| Published in |
Cochrane database of systematic reviews, September 2013
|
| DOI | 10.1002/14651858.cd004289.pub5 |
| Pubmed ID | |
| Authors |
Suetonia C Palmer, Sankar D Navaneethan, Jonathan C Craig, David W Johnson, Vlado Perkovic, Sagar U Nigwekar, Jorgen Hegbrant, Giovanni FM Strippoli |
| Abstract |
People with advanced kidney disease treated with dialysis experience mortality rates from cardiovascular disease that are substantially higher than for the general population. Studies that have assessed the benefits of statins (HMG CoA reductase inhibitors) report conflicting conclusions for people on dialysis and existing meta-analyses have not had sufficient power to determine whether the effects of statins vary with severity of kidney disease. Recently, additional data for the effects of statins in dialysis patients have become available. This is an update of a review first published in 2004 and last updated in 2009. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 15% |
| Canada | 2 | 10% |
| Australia | 1 | 5% |
| Netherlands | 1 | 5% |
| Unknown | 13 | 65% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 65% |
| Scientists | 5 | 25% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
| Practitioners (doctors, other healthcare professionals) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 236 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| India | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 233 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 38 | 16% |
| Student > Bachelor | 28 | 12% |
| Researcher | 19 | 8% |
| Student > Postgraduate | 18 | 8% |
| Other | 16 | 7% |
| Other | 51 | 22% |
| Unknown | 66 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 98 | 42% |
| Nursing and Health Professions | 21 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 3% |
| Psychology | 6 | 3% |
| Agricultural and Biological Sciences | 6 | 3% |
| Other | 22 | 9% |
| Unknown | 75 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2022.
All research outputs
#1,894,142
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#4,032
of 13,140 outputs
Outputs of similar age
#16,215
of 211,807 outputs
Outputs of similar age from Cochrane database of systematic reviews
#90
of 241 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 211,807 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 241 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.